Skip to content
Latest
STOX.NEWS
In focus

Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled

Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years.

Advertisement
Demo creative for ADG8 Article body (336x280)

Companies named

More on this